Jamjoom Pharmaceuticals Factory Company

SASE:4015 Stock Report

Market Cap: ر.س11.5b

Jamjoom Pharmaceuticals Factory Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Tarek Youssef Hosni

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4yrs
CEO ownershipn/a
Management average tenure3.3yrs
Board average tenure2.7yrs

Recent management updates

Recent updates

Jamjoom Pharmaceuticals Factory Company's (TADAWUL:4015) Business Is Yet to Catch Up With Its Share Price

Dec 17
Jamjoom Pharmaceuticals Factory Company's (TADAWUL:4015) Business Is Yet to Catch Up With Its Share Price

Getting In Cheap On Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015) Is Unlikely

Apr 30
Getting In Cheap On Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015) Is Unlikely

CEO

Tarek Youssef Hosni (60 yo)

4yrs

Tenure

Mr. Tarek Youssef Hussein Hosni serves as Chief Executive Officer of Jamjoom Pharmaceuticals Factory Company since February 15, 2021. He has served as the Member of the Board of Directors at Ultra Group Co...


Leadership Team

NamePositionTenureCompensationOwnership
Tarek Youssef Hosni
Chief Executive Officer4yrsno datano data
Ahmed Yousuf Mohammed Jamjoom
Vice Chairman11.1yrsno data4.55%
SAR 524.9m
Anwer Muhiddein
Chief Financial Officer12.1yrsno datano data
Mohammed Jamjoom
Head of Business Operations & Operations Director3.4yrsno datano data
Hussam Salousa
Head of Business Development & Strategy and IR Directorno datano datano data
Ammar Al Attas
Head of the Legal Department & Group Legal Director2.8yrsno datano data
Mazen Serehi
Human Resources Directorno datano datano data
Idrees Siddiqui
Head of Manufacturing Operations2.9yrsno datano data
Faisal Ahmed Linjawi
Board Secretary3.2yrsno datano data

3.3yrs

Average Tenure

43.5yo

Average Age

Experienced Management: 4015's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ahmed Yousuf Mohammed Jamjoom
Vice Chairman11.1yrsno data4.55%
SAR 524.9m
Georges Schorderet
Directorno datano datano data
Noor Ahmed Kather Sheriff
Non-Executive Director2.7yrsno data0.000010%
SAR 1.2k
Mahmoud Yousuf Mohammed Jamjoom
Chairman2.7yrsno data5.6%
SAR 646.0m
Yousuf Mohammed Salah Jamjoom
Non-Executive Director20.1yrsno data41.65%
SAR 4.8b
Mohammed Yousuf Mohammed Jamjoom
Non-Executive Director2.7yrsno data4.55%
SAR 524.9m
Alaa Yousuf Mohammed Jamjoom
Non-Executive Director2.7yrsno data4.55%
SAR 524.9m
Faris Ibrahim Al Ghannam
Non-Executive Independent Director2.7yrsno datano data
Simon Wolfgang Goeller
Non-Executive Independent Director2.7yrsno datano data
Michel Marcel Le Bars
Non-Executive Independent Director2.7yrsno datano data

2.7yrs

Average Tenure

57.5yo

Average Age

Experienced Board: 4015's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/17 20:11
End of Day Share Price 2025/02/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Jamjoom Pharmaceuticals Factory Company is covered by 5 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Madhu AppissaAl Rajhi Capital
null nullJ.P. Morgan
Tarek SleimanJ.P. Morgan